Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Codex adopts food additives

This article was originally published in The Tan Sheet

Executive Summary

The International Alliance of Dietary/Food Supplement Associations is celebrating Codex Alimentarius' adoption of nine widely-used additives at levels proposed by the trade group, IADSA says in a July 6 release. Castor Oil (1,000 mg/kg), Polysorbates (25,000 mg/kg), Polyvinyl Alcohol (45,000 mg/kg), Acesulfame Potassium (2,000 mg/kg), Aspartame (5,500 mg/kg), Cyclamates (1,250 mg/kg), Neotame (90 mg/kg), Saccharin (1,200 mg/kg) and Sucralose (2,400 mg/kg) are now included in the official Codex General Standard for Food Additives following a campaign by IADSA members (1"The Tan Sheet" June 5, 2006, p. 6). IADSA Manager of Regulatory Affairs David Pineda says, "This is an excellent result. The adoption of these additives will help to ensure free trade in dietary supplements across the world and encourage countries to change legislation that is not in conformity with these Codex standards." Additionally, 13 more additives are "due to be considered" for inclusion next year, IADSA notes...

You may also be interested in...

“Critical” Codex Issues Call For U.S. Industry To Think Globally – Consultant

In "a good number of years," decisions made by the Codex Alimentarius Commission will impact legislation in the U.S., according to industry veteran Peter Berry Ottaway

Roche/Genentech Keeps Commitment To External Cancer Innovation

Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.

US FDA Eases Changes For Certain Sterile Injectable Container Closure Materials

To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts